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Abstract
Background: Multimodality treatment improves the chance of survival but increases the risk for long-term side
effects in young cancer survivors, so-called” Adolescents and Young Adults“(AYAs). Compared to the general
population AYAs have a 5 to 15-fold increased risk of cardiovascular morbidity. Thus, improving modifiable lifestyle
risk factors is of particular importance.
Methods: The INAYA trial included AYAs between 18 and 39 years receiving an intensified individual nutrition
counseling at four time points in a 3-month period based on a 3-day dietary record. At week 0 and 12 AYAs got a
face-to-face counseling, at week 2 and 6 by telephone. Primary endpoint was change in nutritional behavior
measured by Healthy Eating Index - European Prospective Investigation into Cancer and Nutrition (HEI-EPIC).
Results: Twenty-three AYAs (11 female, 12 male, median age 20 years (range 19–23 years), median BMI: 21.
4 kg/m2 (range: 19.7–23.9 kg/m2) after completion of cancer treatment for sarcoma (n = 2), carcinoma (n = 2),
blastoma (n = 1), hodgkin lymphoma (n = 12), or leukemia (n = 6) were included (median time between
diagnosis and study inclusion was 44 month).
The primary endpoint was met, with an improvement of 20 points in HEI-EPIC score in 52.2 % (n = 12) of
AYAs. At baseline, median HEI-EPIC score was 47.0 points (range from 40.0 to 55.0 points) and a good,
moderate and bad nutritional intake was seen in 4.3, 73.9 and 21.7 % of AYAs. At week 12, median HEI-EPIC
improved significantly to 65.0 points (range from 55.0 to 76.0 points) (p ≤ 0.001) and a good, moderate and
bad nutritional intake was seen in 47.8, 52.2 and 0 % of AYAs. No change was seen in quality of life, waist-
hip ratio and blood pressure.
Conclusion: Intensified nutrition counseling is feasible and seem to improve nutritional behavior of AYAs.
Further studies will be required to demonstrate long-term sustainability and confirm the results in a
randomized design in larger cohorts.
Trial registration: Clinical trial identifier DRKS00009883 on DRKS
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Background
Multimodality treatment, combining systemic and local
therapies, offer an increasing number of patients the
chance long-term survival or even cure. Currently, the
number of cancer survivors is estimated to be about 15
million in the US rising to about 20 million within the
next decade [1].
While improving treatment results and outcome on
the one side, multimodality treatment may also increase
the risk for physiological, psychological and social long-
term sequelae on the other side. Adolescents and young
adults (AYAs) receiving their cancer treatment during
childhood are at particular risk for long-term side
effects. According to the Childhood Cancer Survivor
study (CCSS, n = 10,397) 2 out of 3 AYAs have treat-
ment related long-term toxicities [2].
The major long-term toxicities and cause of mortality
after treatment of childhood cancer are cardiovascular
diseases like cardiomyopathy, chronic heart failure
(CHF) and valvular problems [3]. Compared to general
population AYAs have a 5 to 15-fold increased risk of
cardiovascular morbidity [3–5]. The individual risk is
determined by treatment related factors (e.g. type of
chemotherapeutic agents, application schedule, number
of cycles, cumulative dose of different agents, and com-
bination with radiotherapy) and non-treatment related
factors (nicotine abuse, diabetes mellitus, dyslipoprotei-
nemia and hypertension [6]. AYAs who have received
anthracycline-based treatment combined with chest
radiation possess the highest risk for cardiovascular late
toxicity, which may further be enhanced by non-
treatment related factors [6].
Whereas large clinical trials are conducted to im-
prove patient outcome, both in terms of cure rates
and reduction of long-term toxicities, prospective
studies evaluating modifications of lifestyle factors as
potential non-treatment related risk factors for long-
term toxicity in AYAs are lacking.
In adult survivors of breast and prostate cancer some
studies have demonstrated that physical activity and
healthy eating can increase survival [7, 8].
The WHEL study showed that telephone nutrition
counseling can achieve major increases in the intake of
micronutrient- and phytochemical-rich vegetables, fruit
and fiber in breast cancer survivors [9]. The ENRGY trial
has shown that a behavioral weight loss intervention can
lead to clinically meaningful weight loss in over-
weight/obese breast cancer survivors [10]. However,
with a median age at diagnosis of more than 60 years for
these cancer survivors, the psychosocial background and
living conditions largely differ from AYAs. Little is known
about the feasibility and the effectiveness of a lifestyle
intervention in an AYA population at risk for cardiovascu-
lar disease.
Furthermore, only 10 % of the cancer survivors are
following a healthy lifestyle without any additional inter-
vention [11]. A large number of cancer survivors are
overweight (58 %), eat less than 5 times per day fruits
and vegetables (82 %) and perform no sport activities
(55 %) [11].
The correlation between nutrition and cardiovascular
disease in AYAs is unknown, but has been intensively
studied in coronary heart disease (CHD) patients. For
this patient group a relevant risk reduction for develop-
ment of CHF by healthy nutrition was demonstrated
(e.g. by 30 % with a Mediterranean diet or by 13 %
following the criteria of “Dietary Approaches to Stop
Hypertension”) [12–14]. Both diets are rich of fibers,
fruits and vegetables, which mirrors the nutrition
recommendations of the “Deutsche Gesellschaft für
Ernährung” (DGE) (see Additional file 1: Table S1 for
recommendations of the DGE) [15]. In CHD patients an
intensive, individualized nutrition counseling leads to an
improvement of nutritional status and behavior and
finally quality of life [13].
The INAYA trial reported here was performed to
evaluate the feasibility and the impact of an intensified




AYAs aged from 18 to 39 years with at least one treat-
ment related (e.g. anthracycline based chemotherapy or
chest radiation) or at least one non-treatment related
(nicotine abuse, diabetes mellitus, dyslipoproteinemia or
hypertension) risk factor for cardiovascular disease were
eligible. All AYAs had completed cancer treatment with
curative intent, were currently considered in remission
and were receiving aftercare within our multidisciplinary
survivorship clinic.
The trial was approved by the institutional review board
and registered (Clinical trial identifier DRKS00009883 on
DRKS). All patients provided written informed consent
before study entry.
Study design
Prior to baseline assessment and after 12 weeks the
AYAs filled in a 3-day dietary record (“Freiburger
Ernährungsprotokoll”) providing data to calculate the
“Healthy Eating Index- European Prospective Investi-
gation into Cancer and Nutrition” (HEI-EPIC) [16].
At baseline and after 12 weeks all AYAs got an intensi-
fied face-to-face nutrition counseling of 60 min per-
formed by the same registered dietitian and based on
the recommendations of the DGE (see Additional file 1:
Table S1) [15]. Depending on the HEI-EPIC results and
reported nutrition problems, recommendations of the
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DGE were modified and individually tailored to the
needs of every AYA. Additionally, demographic informa-
tion and medical history was collected at baseline.
Waist-hip ratio (WHR), body mass index (BMI), blood
pressure (RR), health-related quality of life (HRQOL,
measured by EORTC QLQ-C30 [17]) and laboratory pa-
rameters (AST, ALT, HbA1c, total cholesterol, HDL-
cholesterol, LDL-cholesterol, C-reactive protein (CrP))
were assessed at baseline and after 12 weeks. At weeks 2
and six nutrition counseling of 30 min was repeated by
telephone. (see Fig. 1 for study flowchart).
Healthy eating index - European prospective
investigation into cancer and nutrition
HEI-EPIC is an established instrument to evaluate the
dietary behavior [18]. In the present pilot study the
validated German version of HEI, the HEI-EPIC was
used [16].
The HEI-EPIC distinguishes the following eight food
groups: drinks, vegetables, fruits, cereals/potatoes, milk/
dairy products, meat/sausages/fish/eggs, fats/oil and
sweets/snacks. Based on a calculation described by Rüsten
et al. 0–10 points for each group of food with up to 20
points for fruits, vegetables and drinks were calculated
[16]. The sum score range from 0 to 110 points. A sum
score ≤ 40 points indicate a bad, > 40–64 points a moder-
ate and ≥ 65 points a good dietary behavior [16, 19].
Statistics
The primary endpoint was the rate of AYAs with a rele-
vant improvement in nutritional behavior measured by
HEI-EPIC (increase of at least 20 points) between weeks
0 and 12. Secondary endpoints were the change in
median HEI-EPIC, the assessment of HRQOL by the
EORTC QLQ-C30, WHR, BMI, RR and laboratory as-
sessment regarding dyslipoproteinemia and cholesterine-
mia. Pre-post differences of the secondary endpoints
were analyzed with Wilcoxon test for depended samples
in an exploratory fashion. In addition, retrospective BMI
sub groups were evaluated and patients were classified
as: underweight (≤18.49 kg/m2; n = 5), normal weight
(>18.5–24.99 kg/m2; n = 14) and overweight/obese (≥
25.0–44.99 kg/m2; n = 4). No formal comparison of BMI
subgroups was performed due to small numbers.
Sample size calculation
Based on our experience in the survivorship clinic, about
25 % of patients improve their nutritional behavior
(increase in 20 points in HEI-EPIC) after a general nutri-
tion counseling. With the intensive, individualized nutri-
tion counseling at least 50 % of AYAs should improve
their nutritional intake by 20 points on HEI-EPIC to re-
gard the intervention as meaningful. The probability to
accept the intervention as promising (improvement rate
≥50 % of AYAs), in spite of a true improvement rate of
≤25 % only, was set at 0.1 (type I error). The probability
to erroneously reject the intervention as not sufficiently
efficient (≤25 %), although the true improvement rate is
meaningful (≥50 %) was set at 0.2 (type II error, corre-
sponding to a power of 80 %). According to these pa-
rameters and using a standard single-stage phase II
design with a one sided test and including 10 % drop
outs, n = 21 AYAs had to be recruited [20].
Results
Patients’ characteristics
Twenty-three AYAs, 11 female and 12 male, were in-
cluded in the INAYA study. Median age of cancer diag-
nosis was 16.0 years (range: 10.0–17.0 years), median
age at time of study inclusion was 20.0 years (range:
19.0–23.0 years). Median time between diagnosis and
study inclusion was 44 months (range: 11.0–237 months).
Cancer diagnosis included sarcoma (n = 2), carcinoma
(n = 2), blastoma (n = 1), hodgkin lymphoma (n = 12), or
leukemia (n = 6).
All AYAs (100 %) presented treatment related risks
factors for cardiovascular diseases that were application
of anthracyclines (n = 22, 95.7 %), chest radiation (n = 9,
39.1 %) or both (n = 14, 60.9 %). Additional 8 (34.8 %)
AYAs had non-treatment related risk factors: smoking
(n = 5, 21.7 %), overweight with BMI > 25.0 kg/m2 (n = 4,
17.4 %) and hypertension (n = 1, 4.3 %), but no diabetes
Fig. 1 Study design
Quidde et al. BMC Cancer  (2016) 16:872 Page 3 of 7
mellitus (n = 0, 0 %). One AYA had more than one non-
treatment related risk factor.
Compliance rate was 100 % (n = 23) at baseline and
week 2 but decreased to 73.9 % (n = 17) at week 6 and
69.6 % (n = 16) at week 12. Therefore, overall attrition
rate was 30 %. Reasons for drop out were disease relapse
(n = 1), lack of time due to high work load (n = 1), lack
of time due other reasons (n = 3) and two were lost to
follow up.
Primary endpoint
In 52.2 % (n = 12) of AYAs the median HEI-EPIC score
improved by more than 20 points from baseline to week
12. Thus, the primary endpoint of an improvement in
nutritional behavior by more than 20 points in more
than 50 % of AYAs measured by HEI-EPIC was met,
demonstrating the feasibility of the intensive, individual-
ized nutrition counseling and a high rate of improve-
ment in nutritional behavior.
Secondary endpoints
HEI-EPIC
At baseline, the median HEI-EPIC score was 47.0 points
(range: 40.0–55.0 points) representing a moderate diet-
ary behavior. A good, moderate and bad nutritional in-
take was seen in 4.3, 73.9 and 21.7 % of AYAs. At week
12, median HEI-EPIC score improved significantly to
65.0 points (range: 55.0–76.0 points) (p ≤ 0.001) repre-
senting a good dietary behavior. Good, moderate and
bad nutritional intake was seen in 47.8, 52.2 and 0 % of
AYAs (Fig. 2).
Nutrition scores improved significantly in all food
groups, except meat/sausages/fish/eggs/soy products and
fats/oil (Table 1).
HEI-EPIC score numerically improved in all BMI sub-
groups (Table 2).
Quality of life
For quality of life analysis we used the global health
status/quality of life (GHS/QOL) score of the EORTC
QLQ C-30 questionnaire. The median GHS/QOL score
did not change and was 83.3 points (range: 66.7–91.7
points) at week 0 and 83.3 points (range: 66.7–91.7
points) at week 12 (p = 0.332) (Table 3). A clinical rele-
vant improvement of GHS/QOL score (≥ 10 points) was
seen in 21.7 % (n = 5) of AYAs. While normal weight pa-
tients did not improve their median GHS/QoL (83.3 at
week 0 and 12), patients of under- or overweight seemed
to increase the GHS/QoL score (underweight: 66.7 to
83.3; overweight 75.0 to 87.5 from week 0 to 12).
Detailed results for functioning, symptom and single
item scores of the EORTC QLQ C-30 questionnaire are
shown in Additional file 1: Table S2.
Body Mass Index (BMI)
At baseline 5 AYAs were underweight, 14 AYAs normal
weight and 4 AYAs overweight according to WHO cri-
teria. After nutrition counseling at week 12, the amount
of normal weight AYAs increased to 17, with only four
underweight and two overweight/obese AYAs remaining.
Before nutrition counseling 5 patients claimed weight
loss as one of the goals of taking part in that trial. All of
them reached their aim to lose weight. The overweight/
obese patients (n = 4) lost a median of 4.3 kg (range:
1.4–7.9 kg).
The median BMI at baseline was 21.4 kg/m2 (range:
19.7–23.9 kg/m2) and 20.4 kg/m2 (range: 19.0–23.9 kg/
m2) at week 12 (p = 0.218) (Table 3). In underweight and
normal weight patients the median BMI remained un-
affected 17.7 kg/m2 (range: 16.8–18.0 kg/m2) and
21.4 kg/m2 (range: 20.0–23.4 kg/m2) at baseline and
17.7 kg/m2 (range: 16.8–18.2 kg/m2) and 20.7 kg/m2
(range: 20.0–23.2 kg/m2) at week 12, respectively. In
overweight patients a slight decrease in median BMI
Fig. 2 Nutritional behavior in AYAs at baseline and week 12
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from 29.1 kg/m2 (range: 25.2–40.0 kg/m2) to 27.3 kg/m2
(range: 24.6–37.8 kg/m2) was noted.
Blood pressure (RR)
During the 12 weeks intervention period the median RR
remained stable with 110/70 mmHg (range: 110–125/
70–80 mmHg) at baseline and 110/75 mmHg (range:
105–125/70–80 mmHg) at week 12 (Table 3).
Waist-hip ratio (WHR)
All patients WHR were within the normal range <0.85
for women and <1.0 for men. Median WHR did not
change significantly from baseline to week 12, neither in
the overall population nor in the BMI subgroups.
Median WHR was 0.80 (range: 0.72–0.80) at baseline
and 0.77 (range: 0.71–0.80) at week 12 (p = 0.349).
65.2 % (n = 15) had a lower and 30.4 % (n = 7) had a
higher WHR in week 12 (Table 3). No relevant differ-
ences in WHR changes over time were noted within the
BMI subgroups.
Biochemical parameters (AST, ALT, HbA1c, total cholesterol,
HDL-cholesterol, LDL-cholesterol, CRP)
Intensified nutrition counseling had no significant effect
on biochemical parameters. Detailed results for AST and
ALT, HbA1c, total-cholesterol, LDL-cholesterol, HDL-
cholesterol and CRP are shown in Additional file 1:
Table S3.
Discussion
This first, prospective life-style modification trial in the
particular patient group of AYAs demonstrate the feasi-
bility of an intensified, individual nutrition counseling
and results in high rates of improvement in nutritional
behavior. An improvement of more than 20 points was
seen in 52.2 % (n = 12) of the AYAs. Thus, the pri-
mary endpoint of this study was met. The median
HEI-EPIC score changed significantly from a moder-
ate (47.0 points) to a good nutritional behavior (65.0
points). Overall, the number of AYAs with good nu-
tritional behavior was increased by the INAYA inter-
vention from one to 11.
The AYA population relevantly differs from the elderly
survivor patients and prospective trials in this distinct
setting are lacking. AYAs have to deal with a variety of
relevant problems including educational and occupa-
tional issues, partnership and family planning, besides
lifestyle and nutrition. Of note, compared to previously
reported rates of healthy food intake of up to 18 % in
elderly cancer survivors without nutrition counseling,
the baseline rate in our population seemed to be even
lower (n = 1, 4.3 %) [11].
Despite the particular vulnerability of the AYA popula-
tion prospective trials about nutrition counseling are lack-
ing. The majority of published nutrition intervention trials
include either non-AYA or non-cancer patients. Neverthe-
less, similar to the INAYA trial, a large variety of trials in
different patient population could demonstrate the feasi-
bility and efficacy of lifestyle interventions.
A review of 21 trials about nutrition counseling in
primary care setting demonstrated that moderate- or
high-intensity counseling interventions, including use of
interactive health communication tools, can reduce the
consumption of saturated fat and increase the intake of
fruit and vegetable and therefore improve nutritional
behavior. The patient population included was very
Table 1 Change in median nutrition intake of different HEI-EPIC food groups
Food groups Week 0 (T0) Week 12 (T3) p-value
drinks 4.8 (3.3–9.3) 8.4 (6.9–10.1) 0.001
vegetables 1.8 (0.8–2.4) 3.1 (1.7–3.9) 0.001
fruits 1.5 (0.0–2.4) 2.4 (0.5–3.6) 0.030
cereals/cereals products/potatoes 2.3 (1.7–2.9) 2.9 (2.3–3.4) 0.038
milk/milk products/dairy products 3.3 (1.3–2.9) 1.8 (1.6–3.9) 0.041
meat/sausages/fish/eggs/soy products 1.2 (0.7–1.8) 1.5 (0.8–1.8) 0.452
fats/oil 1.6 (1.2–2.2) 2.1 (1.8–2.6) 0.178
sweets/snacks/alcohol 2.4 (1.4–2.8) 0.9 (0.6–1.8) 0.001
Table 2 HEI-EPIC of different BMI groups




underweight AYAs: 49.0 (38.0–57.5) 78.0 (57.0–80.5)
BMI <18.5 kg/m2
(n = 5)
normal weight AYAs: 50.5 (45.8–56.3) 62.5 (53.3–72.3)
BMI ≥18.5–24.9 kg/m2
(n = 14)
overweight AYAs: 37.5 (27.3–44.0) 60.0 (49.8–69.5)
BMI ≥25.0 kg/m2
(n = 4)
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heterogeneous and is not comparable to AYAs [21]. In
breast cancer patients, a randomized interventional trial
showed a significant improvement in vegetable con-
sumption 8 weeks after nutrition counseling [22]. In re-
gard of dietary behavior, the best-investigated patient
groups are those with hypertension or coronary heart
disease (CHD). In these groups structured educational
programs and intensified nutrition counseling improve
dietary behavior and quality of life [23].
Although survivors usually have an increased risk of
poor HRQOL, the baseline GHS/QoL score was rela-
tively high (83.3 points) in our cohort [24]. HRQOL
assessment refers to a multidimensional construct, con-
sidering the subjective perceptions of disease symptoms,
treatment side effects as well as physical, emotional,
social and cognitive functions. Therefore, it might be
difficult to improve the overall HRQOL by the improve-
ment of nutritional behavior.
Limitations of the INAYA study are the relatively low
number of participants, limiting the interpretation of re-
sults particularly of the subgroup evaluations. Further-
more, the attrition rate of 30 % limits the follow up data.
The availability for phone consultations was limited,
mainly due to educational or occupational engagements
of our AYA patients. Therefore, for future trials the
follow up procedures should be carefully evaluated. One
way could be to send nutrition information and re-
minders by e-Mail, Apps or SMS. Another possibility
could be to extend the intervals and re-counsel the
AYAs at the next regular aftercare appointment. The
relatively short intervention and follow up period does
not allow evaluating the sustained efficacy of the INAYA
protocol. Further trials will need to confirm the sustain-
ability of the INAYA approach, although periodical re-
counseling will likely be necessary to ensure long-term
healthy eating. Due to the single arm design a control-
group is missing and the efficacy of the INAYA approach
cannot be demonstrated. However, a high rate of 50 % of
AYAs with an improvement in nutritional behavior was
noted, clearly pointing towards further evaluation of the
INAYA approach in a randomized setting.
Conclusion
Intensified nutrition counseling is feasible and seem to
improve short-term dietary behavior of AYAs and thus
potentially reduces the long-term risk for developing
cardiovascular diseases. Thus, intensified lifestyle modifi-
cation approaches flanked by long-term follow up are
required in AYAs.
Additional file
Additional file 1: Table S1. 10 guidelines of the German Nutrition
Society (DGE) for a wholesome diet. Table S2. Results of EORTC QLQ C-
30 questionnaire. Table S3. Change in blood values ASAT, ALAT, HbA1c,
Total cholesterol, LDL-cholesterol, HDL-cholesterol and CrP. (DOCX 17 kb)
Abbreviations
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase;
AYA: Adolescents and young adults; BMI: Body mass index; CCSS: Childhood
cancer survivor study; CHD: Chronic heart disease; CHF: Chronic heart failure;
CRP: C-reactive protein; DGE: “Deutsche gesellschaft für ernährung”;
DRKS: Deutsches register klinischer studien; e.g.: Exempli gratia; EORTC QLQ-
C30: European Organisation for Research and Treatment of Cancer Qualitiy of
Life Core Questionnaire 30; GHS/QOL: Global health status/quality of life;
HbA1c: Hemoglobin A1c; HDL-cholesterol: High-density lipoprotein
cholesterol; HEI-EPIC: Healthy eating index - European prospective
investigation into cancer and nutrition; HRQOL: Health-related quality of life;
INAYA: Improved nutrition in AYAs; LDL-cholesterol: Low-density lipoprotein
cholesterol; RR: Blood pressure; S: Supplement; WHR: Waist-hip ratio
Acknowledgments
We want to thank all patients who participated in this study, all participating
clinicians who included patients, and all the staff engaged in this study.
Funding
The study and manuscript was prepared without any funding or
contribution of persons not mentioned in the authors’ section.
Availability of data and materials
For dataset supporting the conclusions of this article please contact the author.
Authors’ contributions
JQ, JG, BK, GE, AS recruited patients, collected patient data, interpreted results of
analyses, prepared, reviewed and input into each stage of the manuscript; GS, LV,
DB, CB: interpreted results of analyses, prepared, reviewed and input into each
stage of the manuscript; All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests. The authors
alone are responsible for the content and writing of the paper.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The trial was performed in accordance with the Declaration of Helsinki and
has been approved by the local ethics committee “Ethik-Kommission der
Ärztekammer Hamburg” on 19/05/2015 (reference number PV4978).
Informed consent to participate in the INAYA study and to publish the
results were obtained from all participants before study inclusion.
Table 3 Secondary endpoints: quality of life, BMI, blood pressure and WHR
Selected secondary endpoints Week 0 (T0) Week 12 (T3) p-value
BMI (kg/m2) 21.4 (19.7–23.9) 20.4 (19.0–23.9) 0.218
Quality of life (GHS/QoL points) 83.3 (66.7–91.7) 83.3 (66.7–91.7) 0.332
Blood pressure (mmHg) 110/70 (105–135/60–90) 110/75 (95–135/60–90) 0.015/0.605
Waist hip ratio (WHR) 0.80 (0.69–0.97) 0.77 (0.66–0.98) 0.349
Quidde et al. BMC Cancer  (2016) 16:872 Page 6 of 7
Author details
1Department of Oncology, Hematology, BMT with Section Pneumology,
Hubertus Wald Tumour Center - University Cancer Center Hamburg,
University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246
Hamburg, Germany. 2Hochschule Neubrandenburg - University of Applied
Sciences, Fachbereich Agrarwirtschaft und Lebensmittelwissenschaften,
Brodaer Straße 2, 17033 Neubrandenburg, Germany. 3Department of
Paediatric Hematology and Oncology, University Hospital
Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany. 4Hamburger
Krebsgesellschaft e.V., Butenfeld 18, 22529 Hamburg, Germany.
Received: 18 May 2016 Accepted: 26 October 2016
References
1. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R,
Robbins AS, Jemal A. Cancer treatment and survivorship statistics, 2014. CA
Cancer J Clin. 2014;64(4):252–71.
2. Wolff SN, Nichols C, Ulman D, Miller A, Kho S, Lofye D, Milford M, Tracy D,
Bellavia B, Armstrong L. Survivorship: an unmet need of the patient with
cancer - implications of a survey of the Lance Armstrong Foundation (LAF).
J Clin Oncol. 2005;23(16_suppl):6032.
3. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows
AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, et al. Chronic
health conditions in adult survivors of childhood cancer. N Engl J Med.
2006;355(15):1572–82.
4. Castellino SM, Geiger AM, Mertens AC, Leisenring WM, Tooze JA, Goodman
P, Stovall M, Robison LL, Hudson MM. Morbidity and mortality in long-term
survivors of Hodgkin lymphoma: a report from the Childhood Cancer
Survivor Study. Blood. 2011;117(6):1806–16.
5. Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M,
Donaldson SS, Green DM, Sklar CA, Robison LL, et al. Cardiac outcomes in a
cohort of adult survivors of childhood and adolescent cancer: retrospective
analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606.
6. Tukenova M, Guibout C, Oberlin O, Doyon F, Mousannif A, Haddy N, Guerin
S, Pacquement H, Aouba A, Hawkins M, et al. Role of cancer treatment in
long-term overall and cardiovascular mortality after childhood cancer.
J Clin Oncol. 2010;28(8):1308–15.
7. Patterson RE, Cadmus LA, Emond JA, Pierce JP. Physical activity, diet,
adiposity and female breast cancer prognosis: a review of the
epidemiologic literature. Maturitas. 2010;66(1):5–15.
8. Rock CL, Demark-Wahnefried W. Can lifestyle modification increase survival in
women diagnosed with breast cancer? J Nutr. 2002;132(11 Suppl):3504S–7.
9. Pierce JP, Newman VA, Flatt SW, Faerber S, Rock CL, Natarajan L, Caan BJ, Gold
EB, Hollenbach KA, Wasserman L, et al. Telephone counseling intervention
increases intakes of micronutrient- and phytochemical-rich vegetables, fruit
and fiber in breast cancer survivors. J Nutr. 2004;134(2):452–8.
10. Rock CL, Flatt SW, Byers TE, Colditz GA, Demark-Wahnefried W, Ganz PA,
Wolin KY, Elias A, Krontiras H, Liu J, et al. Results of the Exercise and
Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A
Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer
Survivors. J Clin Oncol. 2015;33(28):3169–76.
11. Mayer DK, Terrin NC, Menon U, Kreps GL, McCance K, Parsons SK, Mooney KH.
Health behaviors in cancer survivors. Oncol Nurs Forum. 2007;34(3):643–51.
12. Armstrong GT, Oeffinger KC, Chen Y, Kawashima T, Yasui Y, Leisenring W,
Stovall M, Chow EJ, Sklar CA, Mulrooney DA, et al. Modifiable risk factors
and major cardiac events among adult survivors of childhood cancer.
J Clin Oncol. 2013;31(29):3673–80.
13. Chow EJ, Chen Y, Kremer LC, Breslow NE, Hudson MM, Armstrong GT, Border
WL, Feijen EA, Green DM, Meacham LR, et al. Individual prediction of heart
failure among childhood cancer survivors. J Clin Oncol. 2014;10:3643–50.
14. Lipshultz SE, Adams MJ, Colan SD, Constine LS, Herman EH, Hsu DT, Hudson
MM, Kremer LC, Landy DC, Miller TL, et al. Long-term cardiovascular toxicity
in children, adolescents, and young adults who receive cancer therapy:
pathophysiology, course, monitoring, management, prevention, and
research directions: a scientific statement from the American Heart
Association. Circulation. 2013;128(17):1927–95.
15. V.) GNSDGfEe. 10 guidelines of the German Nutrition Society (DGE) for a
wholesome diet. 9th ed. 2013.
16. Ruesten A V. Die Bewertung der Lebensmittelaufnahme mittels eines,
Healthy Eating Index‘(HEI-EPIC). Ernährungs Umschau. 2009;8:450–6.
17. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti
A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization
for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument
for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;
85(5):365–76.
18. Guenther PM, Casavale KO, Reedy J, Kirkpatrick SI, Hiza HA, Kuczynski KJ,
Kahle LL, Krebs-Smith SM. Update of the Healthy Eating Index: HEI-2010.
J Acad Nutr Diet. 2013;113(4):569–80.
19. Center for Nutrition Policy and Promotion USDoA: The Healthy Eating Index:
http://www.cnpp.usda.gov/publications/hei/HEI89-90report.pdf. 1995.
20. Fleming TR. One-sample multiple testing procedure for phase II clinical
trials. Biometrics. 1982;38(1):143–51.
21. Pignone MP, Ammerman A, Fernandez L, Orleans CT, Pender N, Woolf S,
Lohr KN, Sutton S. Counseling to promote a healthy diet in adults: a
summary of the evidence for the U.S. Preventive Services Task Force.
Am J Prev Med. 2003;24(1):75–92.
22. Cho SW, Kim JH, Lee SM, Lee SM, Choi EJ, Jeong J, Park YK. Effect of 8-week
nutrition counseling to increase phytochemical rich fruit and vegetable
consumption in korean breast cancer patients: a randomized controlled
trial. Clin Nutr Res. 2014;3(1):39–47.
23. Cook SL, Nasser R, Comfort BL, Larsen DK. Effect of nutrition counselling on
client perceptions and eating behaviour. Can J Diet Pract Res. 2006;67(4):171–7.
24. Zeltzer LK, Lu Q, Leisenring W, Tsao JCI, Recklitis C, Armstrong G, Mertens
AC, Robison LL, Ness KK. Psychosocial outcomes and health-related quality
of life in adult childhood cancer survivors: a report from the childhood
cancer survivor study. Cancer Epidemiol Biomark Prev. 2008;17(2):435–46.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Quidde et al. BMC Cancer  (2016) 16:872 Page 7 of 7
